Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Vanguard Total Stock Market ETF (NY:VTI)

306.79 -1.24 (-0.40%)
Streaming Delayed Price Updated: 10:43 AM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanguard Total Stock Market ETF

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
64 65 Next >
PNC Financial Services Q1 2025 Earnings Surpass Estimates, But Revenue Falls Short Of Expectations
Provision for credit losses increased to $219 million during the quarter from $155 million in the same period a year ago, reflecting changes in macroeconomic factors and portfolio activity. 
Via Stocktwits
Topics Earnings Economy
An Investor's Take on the Latest Tariff News
Via The Motley Fool
Topics Economy Government World Trade
Citi Q1 2025 Earnings Beat Estimates, CEO Jane Fraser Says US Will Still Be World’s Leading Economy Once Structural Shifts Are Over
Total revenues rose 3% year-over-year to $21.59 billion compared to a Wall Street estimate of $21.29 billion, driven by growth in each of Citi’s five interconnected businesses. 
Via Stocktwits
Topics Derivatives Earnings Economy
Starbucks’ New Dress Code Sparks Worker Backlash, Say Company Is Dodging Core Workplace Issues
In a post on X, Starbucks Workers United said the company is prioritizing superficial branding moves over “real issues like understaffing, fair contracts, and guaranteed hours.” 
Via Stocktwits
Bank Of America Q1 2025 Earnings Beat Estimates: CEO Brian Moynihan Says Bank’s Business Clients Have Been Performing Well
Revenue rose 6% year-over-year to $27.4 billion during the quarter, compared to a Wall Street estimate of $26.91 billion. 
Via Stocktwits
Topics Earnings Economy
Johnson & Johnson’s Q1 Earnings Beat Estimates, 2025 Guidance Revised To Account For Intra-Cellular Therapies Acquisition: Retail’s Positive
The company said the updated guidance includes costs estimated to be incurred as part of Trump’s tariffs on certain imports into the U.S. 
Via Stocktwits
Topics Earnings Government World Trade
Ulta Beauty Downgraded At Argus As Macroeconomic Factors Cast Doubt Over Consumer Discretionary Spending: Retail Mood Neutral
In the company's earnings report last month, management discussed plans to improve the layout and presentation of its stores and promote more wellness products and online sales. 
Via Stocktwits
Allegro Microsystems Stock Slides Premarket After Board Snub Prompts On Semi To Withdraw Buyout Offer : Retail Optimism Tempers
On Semi decided to withdraw its acquisition proposal given the reluctance of Allegro Microsystem’s board to fully engage and explore its proposal. 
Via Stocktwits
Topics Artificial Intelligence
Palantir Retail Investors Brace For Strong Gains As Wedbush Reaffirms ‘Top Names To Own’ Status After NATO AI Contract
Wedbush analyst Daniel Ives said this was another win for the company as more federal customers turn to Palantir for improved AI capabilities in the military. 
Via Stocktwits
Topics Artificial Intelligence Economy Government
Mattel Renews Licensing Partnership For WWE Action Figures, Toys; Shares Rise
The two first came together in 2010, and Mattel has since sold the popular WWE action figures and toys in over 50 markets worldwide. 
Via Stocktwits
Apple Reclaims $3T Market Cap As Wall Street Cheers Trump's Temporary Tariff Relief, But Retail Traders Remain Skeptical
Morgan Stanley now estimates Apple's annualized tariff cost burden to be a much more "manageable" $7 billion, or just 5% of EBIT, versus the $44 billion estimates as of last Thursday. 
Via Stocktwits
Topics Economy Government Supply Chain
FDA Approves Mirum Pharmaceuticals’ Drug For Rare Liver Disease Patients In Tablet Form: Retail Stays Bullish
Livmarli tablets will be available in June through Mirum Access Plus pharmacy. 
Via Stocktwits
Cara Therapeutics Stock Jumps 10% After Announcing 1-for-3 Reverse Stock Split: Retail Sentiment Soars
On Tuesday evening, every three issued and outstanding shares of CARA’s common stock will automatically be combined into one, effectively reducing the number of issued and outstanding shares of the... 
Via Stocktwits
Topics Economy
Intel Sells 51% Stake In Altera To Silver Lake In $4.46B Deal As It Refocuses On Core Business Under New CEO Lip-Bu Tan
Intel will own the remaining 49% of the business, enabling it to participate in Altera’s future success while focusing on its core business. 
Via Stocktwits
Topics Supply Chain
Fate Therapeutics Stock Draws Investor Attention After FDA Grants Special Designation To Its CAR T-Cell Therapy: Retail Stays Optimistic
CEO Bob Valamehr said the RMAT designation recognises the therapy's potential in treating lupus. 
Via Stocktwits
Peter Thiel-Backed Palantir Stock Rallies After NATO Acquires Its AI-Enabled Warfighting System
Palantir’s Maven Smart System NATO (MSS NATO) will be employed within NATO’s Allied Command Operations (ACO), enabling a significant advancement in the modernization of its warfighting capabilities. 
Via Stocktwits
Topics Artificial Intelligence Government
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved
VYKAT XR has now been delivered to the first individuals living with PWS who have been prescribed the medication, the company said. 
Via Stocktwits
Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered
The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at its annual... 
Via Stocktwits
Goldman Sachs Q1 2025 Earnings Beat Wall Street Estimates, Equities Division Reports 27% Jump In Revenues
Total revenue rose 6% year over year to $15.06 billion and surpassed an analyst estimate of $14.71 billion, led by higher net revenues in Global Banking & Markets but partially offset by slightly lower... 
Via Stocktwits
Topics Earnings Government
Sandoz Files Antitrust Lawsuit Against Amgen Over Inflammation Drug, Seeks Damages: Retail Sentiment Falters
Sandoz is seeking an injunction to prevent Amgen from using patent rights to block biosimilar competition and allow Sandoz to launch its Erelzi “as soon as possible.” 
Via Stocktwits
Topics Government Intellectual Property Lawsuit
Bath & Body Works Stock Upgraded By Piper Sandler On Strong Brand Interest, Attractive Share Price: Retail Investors Very Interested
The brand was a popular choice for fragrances among teenagers in the U.S., according to a Piper Sandler survey. 
Via Stocktwits
Nvidia, Alphabet Reportedly Back Ex-OpenAI Exec Ilya Sutskever’s AI Startup Amid Quest For Chip Market Control
SSI’s new funding round, led by Greenoaks, valued the company at around $32 billion. 
Via Stocktwits
Topics Artificial Intelligence Economy Government
10-K Vs. 10-Q Explained: What Every Investor Needs To Know
In this video, we dive into the differences between the 10-K and the 10-Q—two of the most important documents every serious investor should know. 
Via Talk Markets
Topics ETFs Stocks / Equities
GM To Temporarily Halt Production At CAMI Assembly Plant In Ingersoll, Says Unifor: Retail Stays Bearish
GM informed the union of temporary layoffs starting April 14 at CAMI Assembly. Workers will return in May for limited production, and thereafter, production will cease again, with operations idling... 
Via Stocktwits
Topics Workforce World Trade
Warner Bros Discovery Says Veteran John Malone Will Not Stand For Re-Election To Board, Named Chair Emeritus
WBD highlighted that Malone will regularly attend Board meetings and provide strategic counsel and support to the Board and management team. 
Via Stocktwits
Canada Launches Probe Into Cigna’s Express Scripts Over Anti-Competitive Conduct Allegations – But Retail’s Unmoved
Canada’s Competition Bureau is investigating allegations of conduct that can prevent or limit competition in the pharmacy retail market, including “patient steering” and “margin squeezing.” 
Via Stocktwits
Topics Animal Testing
Morgan Stanley Q1 2025 Earnings Surpass Street Expectations, Bank Reports Strong Equity Performance
Revenue rose 17% year-over-year to $17.74 billion during the quarter, surpassing a Wall Street estimate of $16.55 billion. Earnings per share stood at $2.6 versus an estimated $2.21. 
Via Stocktwits
FDA’s Intent To Phase Out Animal Testing Requirement Weighs Down Charles River Stock: Retail’s Disheartened
JPMorgan, which holds a ‘Neutral’ rating on the stock, opined that Charles River could see disruption from customers reassessing its preclinical strategies in the near term. 
Via Stocktwits
Topics Animal Testing
BlackRock’s Larry Fink Says US Very Close To Recession: Believes 90-Day Pause On Tariffs Means Longer, Elevated Uncertainty
Fink said in a prepared statement in the earnings report that uncertainty and anxiety about the future of markets and the economy are dominating client conversations. 
Via Stocktwits
Topics Earnings Economy Government
Wells Fargo Q1 2025 Earnings: Revenue Falls Short Of Estimates, CEO Says Bank Supports Trump Administration’s ‘Willingness To Look At Barriers To Fair Trade’
Revenue rose 3% year-over-year to $20.15 billion, which failed to meet an analyst estimate of $20.76 billion, per FinChat data. Earnings per share stood at $1.39 versus a Street estimate of $1.22. Net... 
Via Stocktwits
Topics Earnings Government
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.